HIV and AIDS Trial, Recruiting (NCT06785376)

HIV and AIDS Trial, Recruiting NCT06785376 Sponsor: Columbia University Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06785376 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who were assigned male sex at birth
People between 18 and 65 years old
People who self-identify as Black, African-American, Afro-Caribbean, Black African, Afro-Latino, or multiethnic Black
People who live in the New York City metro area
People who do not have HIV (testing will be done before the trial begins)
People who have had insertive or receptive anal sex with another man in the past six months
People who are not currently taking PEP or PrEP (HIV prevention or post-exposure medications)
People who communicate in English or Spanish
People who are willing and able to give informed consent to take part in the study

Who may not be able to join:

People who identify as Latino but do not also identify as Black would not meet the ethnic identity requirement for this trial

Notes on eligibility:

Sexual identity (such as gay, bisexual, or straight) is not a factor in whether someone meets the criteria for this trial
People who identify as both Afro-Latino and Black do meet the ethnic identity requirement

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 2128534490

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06785376

Sponsor: Columbia University

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: 2128534490

More information: https://clinicaltrials.gov/study/NCT06785376

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who were assigned male sex at birth
People between 18 and 65 years old
People who self-identify as Black, African-American, Afro-Caribbean, Black African, Afro-Latino, or multiethnic Black
People who live in the New York City metro area
People who do not have HIV (testing will be done before the trial begins)
People who have had insertive or receptive anal sex with another man in the past six months
People who are not currently taking PEP or PrEP (HIV prevention or post-exposure medications)
People who communicate in English or Spanish
People who are willing and able to give informed consent to take part in the study

Who may not be able to join:

People who identify as Latino but do not also identify as Black would not meet the ethnic identity requirement for this trial

Notes on eligibility:

Sexual identity (such as gay, bisexual, or straight) is not a factor in whether someone meets the criteria for this trial
People who identify as both Afro-Latino and Black do meet the ethnic identity requirement

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Columbia University

Registry

ClinicalTrials.gov

Start date

19 December 2024

Est. completion

28 February 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

P3M HIV testing; PrEP uptake

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov